Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis.
Jeong H, Cho H, Kim H, Chae H, Lee JB, Lee K, Kim S, Lee SW, Ryu JS, Kim KW, Chae EJ, Huh J, Park CS, Yoon DH, Suh C.
Jeong H, et al. Among authors: chae h, chae ej.
Blood Adv. 2021 Apr 27;5(8):2142-2152. doi: 10.1182/bloodadvances.2020003947.
Blood Adv. 2021.
PMID: 33881464
Free PMC article.